Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia

Psychiatric Genetics

Volumn 13, Issue 3, 2003, Pages 187-192

  Zhang, Zhi Jun ^a,b   Zhang, Xiao Bin ^a,c   Hou, Gang ^a   Yao, Hui ^a   Reynolds, Gavin P ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c Yangzhou Wutaishan Hospital   (China)

Author keywords

Association study; Dopamine D3 receptor; Functional polymorphism; Manganese superoxide dismutase; Pharmacogenetics; Tardive dyskinesia

Indexed keywords

DOPAMINE 3 RECEPTOR; FREE RADICAL; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; FEMALE; GENETIC ASSOCIATION; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HOSPITAL PATIENT; HUMAN; INVOLUNTARY MOVEMENT; MALE; NEUROTRANSMITTER RELEASE; PHARMACOGENETICS; PRIORITY JOURNAL; RECEPTOR AFFINITY; TARDIVE DYSKINESIA;

AGE OF ONSET; CHINA; DYSKINESIA, DRUG-INDUCED; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE;

EID: 0041331543     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200309000-00010     Document Type: Article

References (29)

1. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH, et al. (1996). A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93:1945-1949.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Washington, DC: American Psychiatric Association.
3. Basile V, Masellis M, Badri F, Paterson AD, Meltzer H, Lieberman JA, et al. (1999). Association of the Mscl polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology 21:17-27.
4. Eichhammer P, Albus M, Borrmann-Hassenbach M, Schoeler A, Putzhammer A, Frick U (2000). Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia. Am J Med Genet 96:187-191.
5. Gaitonde EJ, Morris A, Sivagnanasundaram S, McKenna PJ, Hunt DM, Mollon JD (1996). Assessment of association of D3 dopamine receptor Mscl polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Am J Med Genet 67:455-458.
6. Garcia-Barcelo MM, Lam LCM, Ungvari GS, Lam VKL, Tang WK (2001). Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. J Neural Transm 108:671-677.
7. Glazer WM (2000). Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. J Clin Psychiatry 61(suppl 4):15-20.
8. Griffon N, Crocq MA, Pilon C, Martres MP, Mayerova A, Uyanik G (1996). Dopamine D3 receptor gene: orgnization, transcript variants, and polymorphism associated with schizophrenia. Am J Med Genet 67:63-70.
9. Guy W (1976). ECDEU Assessment for Psychopharmacology. Washington, DC: HEW Public Health Service; pp. 534-537.
10. Hori H, Ohmori O, Shinkai T, Kojima H, Okano C, Suzuki T, Nakamura J (2000). Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacology 23:170-177.
11. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N (2000). Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130:769-773.
12. Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jonsson E, et al. (1992). Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 2:249-256.
13. Liao DL, Yeh YC, Chen HM, Chen H, Hong CJ, Tsai SJ (2001). Association between the ser9gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Neuropsychobiology 44:95-98.
14. Lublin H (1995). Dopamine receptor agonist-and antagonist-induced behaviors in primates previously treated with dopamine receptor antagonists: the pathogenetic mechanisma of acute oral dyskinesia. Clin Neuropharmacol 18:533-551.
15. Lundstrom K, Turpin MP (1996). Proposed schizophrenia-related gene polymorphism: expression of the ser9gly mutant human dopamine D3 receptor with the Semliki forest virus system. Biochem Biophys Res Commun 225:1068-1072.
16. Owens DGC (1999). A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. Cambridge: Cambridge University Press.
17. Ozdemir V, Basile V, Masellis M, Kennedy JL (2001). Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes. J Biochem Biophys Methods 47:151-157
18. Reynolds GP, Brown JC, McCall JC, Mackay AVP (1992). Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study. J Neural Transm Gen Sect 87:225-230.
19. Rietschel M, Krauss H, Muller DJ, Schulze TG, Knapp M, Marwinski K, et al. (2000). Dopamine D3 receptor variant and tardive dyskinesia. Eur Arch Psychiatry Clin Neurosci 250:31-35.
20. Sachdev PS (2000). The current status of tardive dyskinesia. Aust NZ J Psychiatry 34:355-369.
21. Schooler NR, Kane JM (1982). Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:486-487.
22. Segman RH, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafman M, et al. (1999). Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 4:247-253.
23. Segman RH, Heresco-levy U, Finkel B, Inbar R, Neeman T, Schlafman M, et al. (2000). Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5HT2CSer and DRD3Gly alleles to susceptibility. Psychopharmacology (Berl) 152:408-413.
24. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y (1996). Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 226:561-565.
25. Steen VM, Lovlie R, MacEwan T, McCreadie RG (1997). Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol Psychaitry 2:139-145.
26. Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G (1998). D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779:58-74.
27. Van Landeghem GF, Tabatabaie P, Beckman G, Beckman L, Andersen PM (1999). Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neurone diseases. Eur J Neurol 6:639-644.
28. Yassa R, Jeste DV (1992). Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18:701-715.
29. Zhang ZJ, Zhang XB, Hou G, Sha WW, Reynolds GP (2002). The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia in untreated to the Ala-9Val polymorphism. J Psychiatry Res 36:317-324.